Intercellular adhesion molecule-1 (ICAM-1) is an important factor in the progression
of inflammatory responses in vivo. To develop a new
anti-inflammatory drug to block the biological activity of ICAM-1, we produced a
monoclonal antibody (Ka=4.19×10−8 M) against human
ICAM-1. The anti-ICAM-1 single-chain variable antibody fragment (scFv) was expressed
at a high level as inclusion bodies in Escherichia coli. We refolded
the scFv (Ka=2.35×10−7 M) by ion-exchange chromatography,
dialysis, and dilution. The results showed that column chromatography refolding by
high-performance Q Sepharose had remarkable advantages over conventional dilution and
dialysis methods. Furthermore, the anti-ICAM-1 scFv yield of about 60 mg/L was higher
with this method. The purity of the final product was greater than 90%, as shown by
denaturing gel electrophoresis. Enzyme-linked immunosorbent assay, cell culture, and
animal experiments were used to assess the immunological properties and biological
activities of the renatured scFv.
Non-viral gene delivery system with many advantages has a great potential for the future of gene therapy. One inherent obstacle of such approach is the uptake by endocytosis into vesicular compartments. Receptor-mediated gene delivery method holds promise to overcome this obstacle. In this study, we developed a receptor-mediated gene delivery system based on a combination of the Pseudomonas exotoxin A (PE), which has a receptor binding and membrane translocation domain, and the hyperthermophilic archaeal histone (HPhA), which has the DNA binding ability. First, we constructed and expressed the rPE-HPhA fusion protein. We then examined the cytotoxicity and the DNA binding ability of rPE-HPhA. We further assessed the efficiency of transfection of the pEGF-C1 plasmid DNA to CHO cells by the rPE-HPhA system, in comparison to the cationic liposome method. The results showed that the transfection efficiency of rPE-HPhA was higher than that of cationic liposomes. In addition, the rPE-HPhA gene delivery system is non-specific to DNA sequence, topology or targeted cell type. Thus, the rPE-HPhA system can be used for delivering genes of interest into mammalian cells and has great potential to be applied for gene therapy.
The single-chain variable antibody fragment (scFv) against human intercellular adhesion molecule-1 (ICAM-1) was expressed at a high level in Escherichia coli as inclusion bodies. We attempted to refold the scFv by ion-exchange chromatography (IEC), dialysis and dilution. The results show that the column chromatography refolding by Q Sepharose high performance (Q HP) had remarkable advantages over the conventional dilution and dialysis methods. Furthermore, the anti-ICAM-1 scFv yield was higher by this method, which is about 60 mg/l. The purity of the final product was greater than 90%, as shown by denaturing gel electrophoresis. Enzyme-linked immunosorbent assay (ELISA), cell culture and animal experiments were used to assess the immunologic properties and biologic activities of the renatured scFv.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.